14 results
424B3
GRNA
GreenLight Biosciences Inc
6 Oct 22
Prospectus supplement
5:15pm
acceptance of candidate products.
There is typically an extremely high rate of attrition for product candidates across categories of medicines proceeding
424B3
GRNA
GreenLight Biosciences Inc
7 Apr 22
Prospectus supplement
4:02pm
of attrition for product candidates across categories of medicines proceeding through clinical trials. These product candidates may fail to show the desired
POS AM
GRNA
GreenLight Biosciences Inc
5 Apr 22
Prospectus update (post-effective amendment)
5:18pm
.
There is typically an extremely high rate of attrition for product candidates across categories of medicines proceeding through clinical trials
424B3
gpeor48d2f8n2o0t9r5
15 Feb 22
Prospectus supplement
1:38pm
424B3
ag7cwi
13 Jan 22
Prospectus supplement
4:13pm
S-4/A
8q5p5 g64u9
19 Oct 21
Registration of securities issued in business combination transactions (amended)
7:58am
S-4
dct26l2mcel0xff3yca
7 Sep 21
Registration of securities issued in business combination transactions
5:03pm
- Prev
- 1
- Next